Utah Life Sciences News & Events

June 20, 2025

June 30, 2025

This week’s newsletter included:

BIO 2025 International Convention Recap
BioUtah Member Companies Present at BIO 2025
Summit Bioservices Ribbon Cutting
Foldax Secures Approval for TRIA Mitral Heart Valve in India
Nelson Labs to Double Cleanroom Capacity
Halia Therapeutics Completes First-in-Human Phase 1 Study Targeting Neuroinflammation
bioMérieux Strengthens its Next-Generation Sequencing Capabilities with Acquisition of Day Zero Diagnostics Solutions and Technologies
Life Sciences Workforce Collaborative Launches at BIO 2025
Nusano, Ratio Therapeutics, Enter Supply Agreement for Cancer Radiopharmaceuticals
Nusano and dGenThera Sign Letter of Intent for Astatine-211 Supply
Averra Holdings, Banner Capital Announce Partnership with ZIEN Medical
Utah to Sign $57M Settlement with Purdue Pharma Over its Role in Opioid Crisis
University of Utah Breaks Ground on First Off-Campus Hospital
University of Utah Founders Day Distinguished Alumni Awards
Sound Waves and Second Chances: How Spire Therapeutics Is Redefining Brain Treatment
Linder Delivers Keynote Address at CSI in Germany
CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
Utah Business: Nominations for Innovation Awards Open